This is a demo store. No orders will be fulfilled.
Healthcare
Healthcare, the world's largest industry, is transforming faster than ever. The focus on outcomes based medicine and optimal health management of populations will result in major seismic shifts. Modernization and reform measures are being employed globally by public and private sector organizations to meet the growing need for healthcare. New technologies are being created, offering enormous promise to improve care delivery.
Our Transformational Health practice serves all key industry stakeholders through partnership models that provide access to high-quality content and our global team of industry experts. The practice includes Visionary Health, Life Sciences, Advanced Medical Technologies and Connected Health, focusing on evolving healthcare technologies and covering the entire industry spectrum
-
30 Apr 2014  |  Global  |  Market Research
Healthcare News - Vital Signs - The Analysts Perspective - April Issue
This issue of Vital Signs, released on May 1, 2014, discusses the mega deals brewing in the pharma/biotech industry, Pfizer Incs Xalkori for non-small cell lung cancer, Novartis halt on RNAi development efforts, the high-ranked Malaysian healthcare system, Roches acquisition of IQuums Liat Analyzer, and Bio-Rads acquisition of GnuBio.
$450.00 -
18 Apr 2014  |  Global  |  Market Research
Frost & Sullivans 2014 Life Sciences Outlook
Innovative Transformations and Value Creations in Life Sciences
In 2013, healthcare moved towards access, transparency, investments, and spending. In 2014, Frost & Sullivan anticipates new launches to occur across the life sciences spectrum, from preventive medicine to treating complex diseases. This market insight touches upon major events that occurred in 2013 and how 2014 is expected to shape up, includi...
$1,500.00 -
18 Apr 2014  |  Global  |  Market Research
A Strategic Analysis of the Global Anti-obesity Prescription Pharmaceuticals Market
Prescription drug therapy for the treatment of obesity is experiencing a revival of interest with new government incentives and the recent approval of 2 new drugs, with 2 more pending imminent approval. This research service focuses on the competitive landscape of prescription drugs for the treatment of obesity. A global product and pipeline asse...
$3,950.00 -
11 Apr 2014  |  Global  |  Market Research
Survival Strategies for the Global In Vitro Diagnostics Industry
Slowing US and European Markets Demand Alignment with Global Market Needs
While there is a positive outlook for global in vitro diagnostics (IVD), top companies face challenges such as slowing growth, increasing competition, and a changing business environment. This market insight will analyze the current healthcare reality and effective strategies in 2014 and beyond. The study will examine high-growth IVD segments and t...
$1,500.00 -
04 Apr 2014  |  Global  |  Market Research
Global Assessment of Telecommunications Service Providers in Healthcare
Business Model Flexibility to Cater to Unique Market Needs
Telecommunications services are becoming increasingly pervasive in the healthcare industry. Moreover, the role of telecom service providers in delivering care is undergoing a transformation. Numerous products, services and business models have been piloted by some of the leading telecom companies around the world; however, not all have been success...
$4,950.00 -
27 Mar 2014  |  Asia Pacific  |  Market Research
2013 APAC Healthcare Outlook
Changing Dynamics to Disrupt and Transform Healthcare in Asia-Pacific by 2018
Healthcare expenditure in Asia-Pacific is expected to continue growing over the next 6 years, as rising demand for better healthcare for patients spurs reforms. This would also increase life expectancy, resulting in a large elderly population requiring long-term care. This study covers the hospital, life sciences, advanced medical technology, and c...
$2,450.00 -
12 Mar 2014  |  Global  |  Market Research
Product and Pipeline Analysis of the Global Psoriasis Therapeutics Market
Immunoglobulin therapies are life-saving medicines that have been in use for more than 60 years. They provide the patient with a variety of antibodies and are often used as a last line of defense in many severe inflammatory diseases. In some conditions, they are life-saving. However, immunoglobulin therapies are expensive. Despite this, global dem...
$3,950.00 -
27 Feb 2014  |  Asia Pacific  |  Market Research
Product and Pipeline Assessment of the Global Orphan Drugs Market
Attractive Market Lures Hundreds of Innovators, Large and Small
The global market for vaccines is estimated to be only 2-3% of the total pharmaceuticals market in 2014; however, this sector has been continuously experiencing a stellar growth rate of 10-15% per year versus the 5-7% seen in the overall market. Currently, the most commonly available vaccines are administered by injection, which makes mass immuniza...
$3,950.00 -
24 Feb 2014  |  Global  |  Market Research
Frost & Sullivan Awards for Innovations in Allergy Diagnostics and Treatment--Technical Insights
The dermatology space has been transformed with the introduction of biologic therapy for psoriasis, with several additional novel drug classes on the verge of market introduction. This research service provides a comprehensive overview and analysis of marketed and investigational products for the treatment of psoriasis. Information on market backg...
$3,950.00 -
12 Feb 2014  |  Asia Pacific  |  Market Research
Private Equity and Venture Capital Investment in the Global Pharmaceutical and Biotechnology Industry
Vigilance and Equanimity are the Needs of the Hour
The global oncology drug delivery market (or oncolytics market) was worth $91.00 billion in 2013 and has been growing at an annual rate of 5.0%. The market, which includes drug delivery systems for cancer therapy and cancer pain, is expected to generate $100.96 billion in 2015. The oral drug delivery systems segment accounted for an estimated 25.0%...
$4,950.00